Research | OneLook Acronym Finder |
Serial Number | 85030053 |
Registration Number | 4188714 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Domestic Representative | Birch, Stewart, Kolasch & Birch, LLP |
Attorney Name | Robert J. Kenney |
Attorney Docket Number | 1166-0212US1 |
Law Office Assigned | L10 |
Employee Name | CLARK, ROBERT C |
2003-07-16 | Date of First Use |
2010-05-04 | Application Filed |
2012-05-29 | Published for Opposition |
2012-08-14 | Trademark Registered |
2018-07-24 | Location: TMEG LAW OFFICE 101 |
2018-07-24 | Status: Live/Registered |
2018-08-15 | Transaction Date |
Owner: | Yunnan Baiyao Group Co., Ltd. |
Address | No. 3686, Yunnan Baiyao Road Chenggong District Kunming, Yunnan CN _ |
Legal Entity Type | Corporation |
Legal Entity State | CN |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Medicated toothpaste; dietary food supplements; dietary and nutritional supplements; food supplements; nutritional drinks used for meal replacement; medicinal herbal preparation, processed ginseng, panax notoginseng, bee pollen, edible bird's nest, and propolis for medical purposes; herbal supplements; liquid nutritional supplements; medicinal preparations for human purposes, namely, medicinal preparations for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti-inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; pharmaceutical preparations and medicinal preparations in capsule form for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti-inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; pharmaceutical preparations for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti-inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; nervines, namely, nerve calming preparation and pharmaceutical preparations acting on the central nervous system; germicides; medicinal herbs in dried or preserved form; pharmaceutical styptic preparations; biological preparations for medical purposes; medical preparations for slimming purposes; medicines for dental purposes, namely, medicines for use in treatment of pain in the gums and periodontia; edible plant fibers, namely, plant extracts for medical and pharmaceutical purposes; raw medicines, namely, raw materials pharmaceuticals, namely, medicinal herbal extracts for medical purposes, vitamin and mineral preparations for use as ingredients in the pharmaceutical industry; medicinal herbal preparations for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti-inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; medicinal herbal preparations, namely, herbal ointments used for stopping bleeding, relieving pain and anti-inflammatory purposes; poultices; radioactive medicines, namely, radioactive substances for use in nuclear medicine; gases for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; sanitary sterilizing preparations; solutions for contact lenses; cultures of microorganisms for medical and veterinary use; dietetic foods adapted for medical purposes; dietetic food preparations adapted for medical purposes, namely, dietetic beverages for treatment of trace elements, namely, iron, zinc, and calcium deficiency diseases; nutritional additives for use in foods and dietary supplements for human consumption for medical purposes; infant formula, namely, infant milk powder; air purifying preparations, namely, air deodorizer and air freshening preparations; medicines for veterinary purposes, namely, veterinary preparations for treatment of intestinal bacteria, relieving pain, anti-infective and veterinary vaccines; pesticides; herbicides; sanitary towels, namely, sanitary napkins and sanitary pads; sterile paper towel, namely, medicated pre-moistened towelettes; adhesive plaster for medical purposes; gummed medical plasters; medical dressings, namely, gauze and cotton for medical purposes; surgical dressings; surgical tissues, namely, surgical dressings and surgical bandages; first-aid kits; teeth filling material, namely, fillings for teeth; analgesic preparations, namely, an external analgesic aerosol used for relieving pain and anti-inflammatory purposes; diet capsules; diet capsules in the nature of processed ginseng, panax notoginseng, bee pollen, and bird's nest used as an herbal supplement; pharmaceutical preparations, namely, appetite suppressants; nutritional supplements, namely, edible plant fibers for medical purposes in the nature of cereal fibers, xylogen and pectin |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2010-05-07 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2010-05-10 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2010-08-14 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2010-08-16 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2010-08-16 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2010-08-16 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2011-02-15 | 7 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2011-02-15 | 8 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2011-02-16 | 9 TEME I:Incoming Correspondence |
FINAL REFUSAL WRITTEN | 2011-03-09 | 10 CNFR R:Renewal |
FINAL REFUSAL E-MAILED | 2011-03-09 | 11 GNFR O:Outgoing Correspondence |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2011-03-09 | 12 GNFN O:Outgoing Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2011-09-09 | 13 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2011-09-09 | 14 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2011-09-09 | 15 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2011-09-09 | 16 XAEC I:Incoming Correspondence |
NON-FINAL ACTION WRITTEN | 2011-09-29 | 17 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2011-09-29 | 18 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2011-09-29 | 19 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2012-03-24 | 20 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2012-03-24 | 21 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2012-03-26 | 22 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2012-04-03 | 23 CNSA O:Outgoing Correspondence |
ASSIGNED TO LIE | 2012-04-23 | 24 ALIE A:Allowance for Publication |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2012-04-23 | 25 PREV O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2012-05-09 | 26 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2012-05-29 | 27 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2012-05-29 | 28 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2012-08-14 | 29 R.PR A:Allowance for Publication |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2017-08-14 | 30 REM1 E:E-Mail |
TEAS SECTION 8 & 15 RECEIVED | 2018-07-12 | 31 E815 I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2018-07-24 | 32 APRE A:Allowance for Publication |
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2018-07-24 | 33 C15A O:Outgoing Correspondence |
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2018-07-24 | 34 NA85 E:E-Mail |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2018-08-06 | 35 COAR I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2018-08-06 | 36 CHAN I:Incoming Correspondence |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2018-08-09 | 37 COAR I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2018-08-09 | 38 CHAN I:Incoming Correspondence |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2018-08-14 | 39 COAR I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2018-08-14 | 40 CHAN I:Incoming Correspondence |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-11-16 | 41 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-11-16 | 42 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-11-16 | 43 ARAA I:Incoming Correspondence |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2020-11-16 | 44 EWAF I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-11-16 | 45 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-11-16 | 46 CHAN I:Incoming Correspondence |
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2021-08-14 | 47 REM2 E:E-Mail |
TEAS SECTION 8 & 9 RECEIVED | 2022-06-09 | 48 E89R I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-12-23 | 49 APRE A:Allowance for Publication |
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2022-12-24 | 50 89AG O:Outgoing Correspondence |
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2022-12-24 | 51 RNL1 Q: |
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2022-12-24 | 52 NA89 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.